FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501
Go back to FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501| Amgen Inc (NASDAQ: AMGN) | Delayed: 351.43 +4.42 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $347.01 | 52 Week High | $176.85 | |||
| Open | $348.00 | 52 Week Low | $133.64 | |||
| Day High | $354.42 | P/E | 52.93 | |||
| Day Low | $346.00 | EPS | $6.64 | |||
| Volume | 2,364,221 | |||||
